The Diabetech Roundup
The latest in diabetes tech and what it all means
Connect
PharmaSens showed me two prototypes for its combined CGM & insulin pump currently in development.
While Omnipod 5 offers less customization than DIY apps, it has some impressive advantages.
Medtronics has a new CGM and Eversense 365 gets clearance as a 1-year implantable CGM.
A colorful hybrid closed-loop insulin pump powered by an ultra-customizable algorithm.
The disposable sensor is 50% smaller and works with Medtronic's smart insulin pen.
The Inreda pump uses both insulin and glucagon to regulate glucose levels.
An all-in-one pump and CGM could be coming soon and I tested out the Omnipod 5 for three months.
A recent study could alter the standard of diabetes care and access to CGMs
I get into the impressive tech from from this year's EASD Conference.
